Evogene
EVGN
EVGN
42 hedge funds and large institutions have $10M invested in Evogene in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
40% less capital invested
Capital invested by funds: $16.7M → $10M (-$6.65M)
96% less call options, than puts
Call options by funds: $14K | Put options by funds: $361K
Holders
42
Holding in Top 10
–
Calls
$14K
Puts
$361K
Top Buyers
1 | +$235K | |
2 | +$222K | |
3 | +$185K | |
4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$94K |
5 |
Jane Street
New York
|
+$83.1K |
Top Sellers
1 | -$696K | |
2 | -$316K | |
3 | -$258K | |
4 |
PP
PDT Partners
New York
|
-$204K |
5 |
Squarepoint
New York
|
-$120K |